MADRIGAL PHARMACEUTICALS INC (MDGL:NASDAQ)
$523.26 -16.8 (-3.1108%)
Analysed MADRIGAL PHARMACEUTICALS INC (MDGL:NASDAQ) News Sources
Madrigal (MDGL) Reports Q2 Loss, Beats Revenue Estimates
30-07-2026
yahoo.com
Madrigal Pharmaceuticals Q2 Earnings Call Highlights
30-07-2026
marketbeat.com
Madrigal Pharmaceuticals (MDGL) Beat Earnings Estimates, Is It Still Below Fair Value?
31-07-2026
yahoo.com
Madrigal Pharmaceuticals to Participate in the Canaccord Genuity 45th Annual Growth Conference
06-08-2026
yahoo.com
Madrigal Appoints John C. Reed, M.D., Ph.D., to its Board of Directors
12-08-2026
yahoo.com
Madrigal’s Rezdiffra Hits $1.3B Run Rate as MASH Pipeline Expands
15-08-2026
marketbeat.com
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
20-08-2026
yahoo.com
Here's Exactly What It Will Take for Madrigal Pharmaceuticals Stock to Take Off
25-08-2026
fool.com
Madrigal Pharmaceuticals to Participate in the 2026 Cantor Global Healthcare Conference
02-09-2026
yahoo.com
Institutional Investors Are Loading Up on Madrigal Pharmaceuticals Stock. Should You?
10-09-2026
fool.com
What is the current price of MADRIGAL PHARMACEUTICALS INC (MDGL:NASDAQ)?
The current price of MADRIGAL PHARMACEUTICALS INC (MDGL:NASDAQ) is $523.26.
MADRIGAL PHARMACEUTICALS INC (MDGL:NASDAQ) absolute price change since previous trading day?
The absolute price change of MADRIGAL PHARMACEUTICALS INC (MDGL:NASDAQ) since the previous trading day is $-16.8.
MADRIGAL PHARMACEUTICALS INC (MDGL:NASDAQ) percentage price change since previous trading day?
The percentage price change of MADRIGAL PHARMACEUTICALS INC (MDGL:NASDAQ) since the previous trading day is -3.1108%.
What is the most recent average sentiment score for MADRIGAL PHARMACEUTICALS INC (MDGL:NASDAQ)?
The most recent average sentiment score for MADRIGAL PHARMACEUTICALS INC (MDGL:NASDAQ) is 79 out of 100.
What is the most recent average sentiment for MADRIGAL PHARMACEUTICALS INC (MDGL:NASDAQ)?
The most recent sentiment for MADRIGAL PHARMACEUTICALS INC (MDGL:NASDAQ) is .
SEC-8K** Filing Available For MADRIGAL PHARMACEUTICALS INC (MDGL:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.